Evofem Biosciences, Inc. Purchase Agreements
27 Contracts & Agreements
- Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of September 20, 2024 (Filed With SEC on September 25, 2024)
- Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of August 9, 2024 (Filed With SEC on August 14, 2024)
- Securities Purchase Agreement, by and between the Company and Aditxt, Inc., dated as of July 12, 2024 (Filed With SEC on July 23, 2024)
- Asset Purchase Agreement, by and between the Company and Lupin Inc (Filed With SEC on July 18, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on October 3, 2023)
- Fourth Amendment to Securities Purchase and Security Agreement (Filed With SEC on September 11, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on August 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on April 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 24, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 14, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on February 23, 2023)
- Second Amendment to Securities Purchase Agreement, dated as of September 15, 2022, by and among Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, LP, and Adjuvant... (Filed With SEC on September 16, 2022)
- Third Amendment to Securities Purchase and Security Agreement, dated as of September 15, 2022, by and among Evofem Biosciences, Inc., certain institutional investor and their... (Filed With SEC on September 16, 2022)
- First Amendment to Securities Purchase Agreement, dated as of October 14, 2020, by and among Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, LP, and Adjuvant... (Filed With SEC on April 7, 2022)
- Second Amendment to Securities Purchase and Security Agreement, dated as of April 23, 2020, by and among Evofem Biosciences, Inc., certain affiliates of Baker Bros. Advisors LP,... (Filed With SEC on March 21, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on March 1, 2022)
- Purchase Agreement (Filed With SEC on February 16, 2022)
- Purchase Agreement (Filed With SEC on February 16, 2022)
- Securities Purchase Agreement (Filed With SEC on January 13, 2022)
- First Amendment to Securities Purchase and Security Agreement, dated as of April 23, 2020, by and among Evofem Biosciences, Inc., certain affiliates of Baker Bros. Advisors LP, as... (Filed With SEC on November 22, 2021)
- Securities Purchase Agreement, dated October 11, 2021 (Filed With SEC on October 12, 2021)
- Securities Purchase Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health... (Filed With SEC on October 15, 2020)
- Securities Purchase and Security Agreement, dated as of April 23, 2020, by and between Evofem Biosciences, Inc., its wholly-owned domestic subsidiaries as guarantors, certain... (Filed With SEC on April 27, 2020)
- Securities Purchase Agreement (Filed With SEC on April 11, 2019)
- Securities Purchase Agreement, dated October 17, 2017, by and among the Company, Evofem Biosciences, Inc. and the investors listed therein (Filed With SEC on October 17, 2017)
- Neothetics, Inc. 2014EMPLOYEE STOCK PURCHASE PLAN Neothetics, Inc. 2014 Employee Stock Purchase Plan (Filed With SEC on November 10, 2014)
